Das „French Paradox”

Literatur

• 1 Bingen H. Causae et Curae. Therapeutische Monatshefte, 16. Jahrgang, Berlin Übersetzung Dr. phil. Kaiser 1902
• 2 Bollinger. Über die Häufigkeit und Ursachen der idiopathischen Herzhypertrophie in München.  Dtsch Med Wochenschr. 1884;  12
• 3 Camacho T C, Kaplan G A, Cohen R D. Alcohol consumption and mortality in Alameda county.  J Chronic Dis. 1987;  40 229-236
• 4 Criqui M H, Ringel B L. Does diet or alcohol explain the French Paradox.  Lancet. 1994;  344 1719-1723
• 5 De Lorgeril M, Salen P, Marin J L, Boucher F, Paillard F, de Leiris J. Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction.  Circulation. 2002;  106 1465-1469
• 6 De Oliveira E, Silva E R, Foster D, McGee H M, Seidman C E, Smith J D, Breslow J L. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II.  Circulation. 2000;  102 2347-2352
• 7 Di Castelnuovo A, Rotondo S, Iacoviello L, Donati M B, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk.  Circulation. 2002;  105 2836-2844
• 8 Dyer A R, Stamler J, Paul O, Berkson D M, Lepper M H, Shekelle R B, McKean H, Garside D. Alcohol consumption and 17-year mortality in the Chicago western electric company study.  Rev Med. 1980;  9 78-90
• 9 Flesch M, Erdmann E, Böhm M. Alkohol und Myokardinfarkt. Epidemiologische und experimentelle Untersuchungen zum Einfluss von Alkohol auf Gefäßrelaxation und Koronarsklerose.  Dtsch Med Wochenschr. 1998;  123 1490-1496
• 10 Flesch M, Schwarz A, Böhm M. Different effects of red and white wine on endothelial-dependent vasorelaxation of coronary arteries.  Am J Physiol. 1998;  1998 H1183-H1190
• 11 Frankel E N, Kanner J, German J B, Parks E, Kinsella J E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine.  Lancet. 1993;  341 454-457
• 12 Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber C S. High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism.  N Engl J Med. 1990;  322 95-99
• 13 Friedman L A, Kimball A W. Coronary heart disease mortality and alcohol consumption in Framingham.  Am J Epidemiol. 1986;  124 481-489
• 14 Fuchs C S, Stampfer M J, Golditz G A, Giovanucci E L, Manson J E, Kawachi I, Hunter D J, Hankinson S E, Hennekens C, Rosner B, Speizer F D, Willet W C. Alcohol consumption and mortality among women.  N Engl J Med. 1995;  332 1245-1250
• 15 Garfinkel L, Bofetta P, Stellman S. Alcohol and breast cancer: a cohort study.  Prev Med. 1988;  17 686-693
• 16 Gaziano J M, Buring J E, Breslow J L, Goldhaber S U, Rosner B, van Denburgh M, Willet W, Hennekens C H. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction.  N Engl J Med. 1993;  329 1829-1834
• 17 Goldberg U, Mosca L, Piano M R, Fisher E A. Wine and your heart: A science advisory for healthcare professionals from the nutrition committee, council on epidemiology and prevention, and council on cardiovascular nursing of the American Heart Association.  Circulation. 2001;  103 472-475
• 18 Gronbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein H O. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer.  Ann Intern Med. 2000;  19 411-419
• 19 Gronbaek M, Dies A, Sorensen T IA, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits.  BMJ. 1995;  310 1165-1169
• 20 Hart C E. PDGF β receptor blockade inhibits intimal hyperplasia in the baboon.  Circulation. 1999;  99 564-569
• 21 Hines L M, Stampfer M J, Ma J, Gaziano J M, Ridker P M, Hankinson S E, Sacks F, Rimm E B, Hunter D J. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction.  N Engl J Med. 2001;  344 549-555
• 22 Keevil J G, Osman H E, Reed J D, Folts J D. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation.  J Nutr. 2000;  130 53-56
• 23 Keil U, Chambless L E, Doring A, Filipiak B, Stieber J. The relation of alcohol intake to coronary heart disease and all-cause mortality in a beer drinking population.  Epidemiology. 1997;  8 150-156
• 24 Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease.  Curr Opin Lipidol. 2001;  12 383-389
• 25 Klatsky A L, Armstrong M A, Friedman G D. Alcohol and mortality.  Ann Intern Med. 1992;  117 646-654
• 26 Klatsky A l, Friedman G D, Siegelaub A B. Alcohol use and cardiovascular disease: the Kaiser-Permanente experience.  Circulation. 1981;  64 32-41
• 27 Leikert J F, Räthel T R, Wohlfart P, Chéynier V, Vollmar A M, Dirsch V M. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells.  Circulation. 2002;  106 1614-1617
• 28 Longnecker M P. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review.  Cancer Causes Control. 1994;  5 73-82
• 29 Lowenstein S R, Gabow P A, Cramer J, Oliva P D, Ratner K. The role of alcohol in new-onset atrial fibrillation.  Arch Intern Med. 1983;  143 1882-1885
• 30 Luis A J. Atherosclerosis.  ature. 2000;  407 233-241
• 31 Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum.  Lancet. 1994;  344 193-194
• 32 Meade T W, Chakrabarti R, Haines A P, North W RS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.  BMJ. 1979;  1 153-156
• 33 Mukamal K J, Maclure M, Muller J E, Sherwood J B, Mittleman M A. Prior alcohol consumption and mortality following acute myocardial infarction.  JAMA. 2001;  285 1965-1970
• 34 National Center for Health Statistics .Vital statistics of the United States: mortality series,. Washington, D. C.Government Printing Office 1968 - 1988
• 35 Nishikawa M, Ishikawa T, Ito T, Shige H, Tomiyasu K, Nakajima K, Kondo K, Hashimoto H, Saitoh K, Manabe M. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin: cholesterol acyltransferase in high-density lipoprotein cholesterol elevation.  Atherosclerosis. 1994;  111 99-109
• 36 Norton R, Batey R, Dwyer T, MacMahon S. Alcohol consumption and the risk of alcohol cirrhosis in women.  BMJ. 1987;  295 8082
• 37 Pace-Asiak C R, Hahn S, Diamandis E P, Soleas G, Goldberg D M. The red wine phenolics trans-resveratrol and quercetin block huma platelet aggregation and eicosanoid synthesis. Implications for protection against coronary heart disease.  Clinica chemica acta. 1995;  235 207-219
• 38 Renaud S G, Beswick A D, Fehily A M, Sharp D S, Elwood P C. Alcohol and platelet aggregation: the Caerphilly prospective heart disease study.  Am J Clin Nutr. 1992;  55 1012-1017
• 39 Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease.  Lancet. 1992;  339 1523-1526
• 40 Ridker P M, Vaughan D E, Stampfer M J, Glynn R J, Hennekens C H. Association of moderate alcohol consumption and plasma concentrations of endogenous tissue-typ plasminogen activator.  JAMA. 1994;  27 929-933
• 41 Rimm E B, Giovannucci E L, Willet W C, Golditz G A, Ascherioi A, Rosner B, Stampfer M J. Prospective study of alcohol consumption and risk of coronary disease in men.  Lancet. 1991;  338 464-468
• 42 Rimm E B, Stampfer M J. Wine, beer, and spirits. Are they really horses of a different color?.  Circulation. 2002;  105 2806-2807
• 43 Rogers S, Yarnell J WG, Fehily A M. Nutritional determinants of haemostatic factors ii the Caerphilly study.  Eur J Clin Nutr. 1988;  42 197-205
• 44 Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Böhm M. Inhibition of the PDGF receptor by red wine flaonoids provides a molecular explanation for the „French paradox”.  FASEB J. 2002;  16 1958-1960
• 45 Ross R. Atherosclerosis - an inflammatory disease.  N Engl J Med. 1999;  340 115-126
• 46 Sano H. Functional blockade of platelet-derived growth factor receptor-β but not of receptor-α prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice.  Circulation. 2001;  103 2955-2960
• 47 Schipperges H. Moderne Medizin im Spiegel der Geschichte. Thieme, Stuttgart 1970: 124
• 48 Shaper A G, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve.  Lancet. 1988;  2 1267-1273
• 49 Shimada K, Watanabe H, Hosoda K, Takeuchi K, Yoshikawa J. Effect of red wine on coronary flow-velocity reserve.  Lancet. 1999;  354 1002
• 50 Solomon C G, Hu F B, Stampfer M J, Golditz G A, Speizer F E, Rimm E B, Willert W C, Manson J E. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus.  Circulation. 2000;  102 494-499
• 51 Teragawa H, Fukuda Y, Matsuda K, Higashi Y, Yamagata T, Matsuura H, Chayama K. Effet of alcohol consumption on endothelial function in men with coronary artery disease.  Atherosclerosis. 2002;  165 145-152
• 52 Truelsen T, Gronbaek M, Schnohr P, Boysen G. Intake of beer, wine, and spirits and risk of stroke: the copenhagen city heart study.  Stroke. 1998;  29 2467-2472
• 53 Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Förstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.  Circulation. 2002;  106 1652-1658